Brief: Dogwood Therapeutics Q2 EPS USD -0.34
13/08/2026 13:31
BRIEF-Dogwood Therapeutics Q2 EPS USD -0.34 Aug 13 (Reuters) - Dogwood Therapeutics Q2 net income USD -11.5 million.
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study